Ann: Response to article in 'Margin Call', page-72

I thought he was doing better than OK .
- Market leadership from failure in UK and Germany.
- Sustained growth in a relatively small sector in the US and either leadership or challenger 2 position
- Created MTX from existing product to enter other market sectors and filed for registration of full thickness products which will turbo charge other sectors.
- Entered a large emerging market to create a new profitable model for the largest burns markets geographically. Hard process but positive results in the private sector training surgeons in our product and first of 50+ government tenders put in approved and will come on stream within 3-6 months others will probably follow reasonably after that.
- Hernia project rescued and ready to go through preliminary trials .
- Supply strategy undertaken and new facilities being commissioned.
- Built strong management team after constant revolving door.
- Progressed additional funding from BARDA and approvals with FDA.

That’s better than OK and although we all love David I don’t think we need to denigrate the achievements of Swami or our company. I don’t know the truth of what’s happened but todays article clearly says “ Raote is based in the US and didn’t respond to our inquiries “ so all the negative speculation on him putting it out there is incorrect . This whole sorry saga is very disappointing to me as a shareholder.